Form4.ai tracks every SEC insider trade in real time. See every AURX insider filing with a free account — no card.
See every AURX insider filing — free account, no card.
Free accountNuo Therapeutics, Inc. (AURX) has 2 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $10K. Most recent filing: Oct. 6, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Aug 31, 2026 SEC filing Amended: Corrected by the insider on Aug 31, 2026 | JORDEN DAVID EMERSON CEO/CFO | Bought | $9,539 | +15.0% 30D |
Create a free account to see all 2 AURX filings from the last 90 days. No card needed.
Create free accountWant AURX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.